Drug intelligence / Profile preview

milk gangliosides

Development stage
Preclinical
Lead developer
CarboCode
Modality
Lipid-based Nanoparticles → Nanoparticles → Drug Delivery Systems
Administration
Oral
01

Overview

Milk gangliosides are a **non-single-entity mixture of sialylated glycosphingolipids** naturally enriched in the milk fat globule membrane, with **GM3 and GD3** as the principal species reported in bovine and human milk. In the provided literature, they are used primarily as a **nutritional bioactive ingredient / nutraceutical** rather than a conventional pharmaceutical, most often by **oral dietary supplementation**. Their proposed mechanisms are not target-specific in the classic drug sense; instead, they appear to act through **membrane glycan-mediated host-pathogen decoy effects**, **modulation of gut barrier integrity and permeability**, **effects on intestinal microbiota and immune development**, and possible **support of neurodevelopment**. Public-source evidence includes multiple peer-reviewed publications describing dietary milk gangliosides in preclinical models, including work suggesting benefit in **GM3 synthase deficiency** models and in intestinal barrier biology, but there is no clear evidence in the supplied material of a uniquely branded, sponsor-developed pharmaceutical product based on this exact substance mixture.

Other names
milk gangliosidesbovine milk gangliosidesoral bovine milk gangliosidesmilk GG
02

Targets

Pathogen adhesins/lectins recognizing sialylated glycolipids

Beyond the preview

Go deeper on milk gangliosides.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on milk gangliosides.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call